ACADIA Pharmaceuticals Inc (ACAD)
16.73
+0.42
(+2.58%)
USD |
NASDAQ |
Apr 26, 15:59
ACADIA Pharmaceuticals Price: 16.73 for April 26, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 25, 2024 | 16.50 | 16.51 | 16.16 | 16.31 | 1.633M |
Apr 24, 2024 | 16.81 | 16.86 | 16.55 | 16.59 | 1.297M |
Apr 23, 2024 | 17.09 | 17.24 | 16.60 | 16.74 | 1.476M |
Apr 22, 2024 | 17.05 | 17.34 | 16.94 | 16.99 | 1.157M |
Apr 19, 2024 | 16.98 | 17.30 | 16.62 | 16.82 | 3.628M |
Apr 18, 2024 | 17.26 | 17.35 | 17.01 | 17.07 | 988365.0 |
Apr 17, 2024 | 17.25 | 17.25 | 16.97 | 17.19 | 1.028M |
Apr 16, 2024 | 16.75 | 17.20 | 16.60 | 17.08 | 978294.0 |
Apr 15, 2024 | 17.13 | 17.28 | 16.76 | 16.89 | 1.112M |
Apr 12, 2024 | 17.40 | 17.62 | 16.85 | 17.14 | 1.296M |
Apr 11, 2024 | 17.90 | 17.90 | 17.34 | 17.41 | 1.522M |
Apr 10, 2024 | 17.72 | 17.77 | 17.55 | 17.73 | 1.147M |
Apr 09, 2024 | 17.94 | 18.24 | 17.84 | 18.15 | 1.372M |
Apr 08, 2024 | 17.87 | 18.08 | 17.63 | 17.80 | 1.725M |
Apr 05, 2024 | 17.91 | 18.25 | 17.61 | 18.01 | 1.523M |
Apr 04, 2024 | 18.52 | 18.63 | 18.02 | 18.05 | 1.168M |
Apr 03, 2024 | 18.00 | 18.46 | 18.00 | 18.42 | 1.334M |
Apr 02, 2024 | 18.04 | 18.25 | 17.86 | 18.11 | 1.276M |
Apr 01, 2024 | 18.59 | 18.59 | 17.91 | 18.26 | 1.243M |
Mar 28, 2024 | 18.20 | 18.50 | 18.05 | 18.49 | 1.532M |
Mar 27, 2024 | 17.90 | 18.20 | 17.73 | 18.20 | 1.701M |
Mar 26, 2024 | 17.95 | 18.03 | 17.68 | 17.79 | 1.445M |
Mar 25, 2024 | 18.00 | 18.20 | 17.56 | 17.84 | 1.845M |
Mar 22, 2024 | 18.34 | 18.39 | 17.91 | 17.95 | 1.481M |
Mar 21, 2024 | 18.67 | 19.00 | 18.31 | 18.41 | 1.968M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
13.01
Minimum
Jun 21 2022
57.00
Maximum
Jul 07 2020
28.83
Average
24.66
Median
Price Benchmarks
Tonix Pharmaceuticals Holding Corp | 0.1683 |
Amylyx Pharmaceuticals Inc | 1.755 |
Regulus Therapeutics Inc | 2.41 |
Minerva Neurosciences Inc | 2.44 |
Viking Therapeutics Inc | 74.34 |
Price Related Metrics
PS Ratio | 3.779 |
Price to Book Value | 6.385 |
Earnings Yield | -2.27% |
Market Cap | 2.757B |